![H. Hogan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Hogan
Directeur/Membre du Conseil chez
METACRINE, INC.
Profil
H.
Michael Hogan currently works at Otonomy, Inc., as Director from 2023 and Metacrine, Inc., as Director from 2023.
Mr. Hogan also formerly worked at Nabriva Therapeutics Plc, as Chief Executive Officer and Armanino LLP (United States), as Partner.
Mr. Hogan received his undergraduate degree from Colgate University.
Postes actifs de H. Hogan
| Sociétés | Poste | Début |
|---|---|---|
| METACRINE, INC. | Directeur/Membre du Conseil | 23/03/2023 |
| OTONOMY | Directeur/Membre du Conseil | 15/02/2023 |
Anciens postes connus de H. Hogan
| Sociétés | Poste | Fin |
|---|---|---|
Armanino LLP (United States)
 Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Corporate Officer/Principal | - |
| NABRIVA THERAPEUTICS PLC | Directeur Général | - |
Formation de H. Hogan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armanino LLP (United States)
Armanino LLP (United States) Miscellaneous Commercial ServicesCommercial Services Operates as an accounting and consulting firm | Commercial Services |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
